Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Kauhava, Lea
Immonen-Räihä, Pirjo
Parvinen, Ilmo
Holli, Kaija
Pylkkänen, Liisa
Kaljonen, Anne
Helenius, Hans
Kronqvist, Pauliina
and
Klemi, Pekka J.
2008.
Lower recurrence risk through mammographic screening reduces breast cancer treatment costs.
The Breast,
Vol. 17,
Issue. 6,
p.
550.
Lidgren, M.
Jönsson, B.
Rehnberg, C.
Willking, N.
and
Bergh, J.
2008.
Cost-effectiveness of HER2 testing and 1-year adjuvant trastuzumab therapy for early breast cancer.
Annals of Oncology,
Vol. 19,
Issue. 3,
p.
487.
Lauzier, S.
Maunsell, E.
Drolet, M.
Coyle, D.
Hebert-Croteau, N.
Brisson, J.
Masse, B.
Abdous, B.
Robidoux, A.
and
Robert, J.
2008.
Wage Losses in the Year After Breast Cancer: Extent and Determinants Among Canadian Women.
JNCI Journal of the National Cancer Institute,
Vol. 100,
Issue. 5,
p.
321.
Lidgren, Mathias
Wilking, Nils
Jönsson, Bengt
and
Rehnberg, Clas
2008.
Cost-effectiveness of HER2 testing and trastuzumab therapy for metastatic breast cancer.
Acta Oncologica,
Vol. 47,
Issue. 6,
p.
1018.
Damm, Oliver
Hodek, Jan-Marc
and
Greiner, Wolfgang
2009.
Methodische Standards von Krankheitskostenstudien am Beispiel von Brust-, Prostata- und Darmkrebs.
Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen,
Vol. 103,
Issue. 6,
p.
305.
Koinberg, Ingalill
Engholm, G.-B.
Genell, A.
and
Holmberg, L.
2009.
A health economic evaluation of follow-up after breast cancer surgery: Results of an rct study.
Acta Oncologica,
Vol. 48,
Issue. 1,
p.
99.
Dahlberg, L.
Lundkvist, J.
and
Lindman, H.
2009.
Health care costs for treatment of disseminated breast cancer.
European Journal of Cancer,
Vol. 45,
Issue. 11,
p.
1987.
Lekander, Ingrid
Borgström, Fredrik
Ström, Oskar
Zethraeus, Niklas
and
Kanis, John A
2009.
Cost-Effectiveness of Hormone Therapy in the United States.
Journal of Women's Health,
Vol. 18,
Issue. 10,
p.
1669.
Lauzier, Sophie
Maunsell, Elizabeth
Drolet, Mélanie
Coyle, Douglas
and
Hébert-Croteau, Nicole
2010.
Validity of information obtained from a method for estimating cancer costs from the perspective of patients and caregivers.
Quality of Life Research,
Vol. 19,
Issue. 2,
p.
177.
Earle, Craig C.
Chretien, Yves
Morris, Carl
Ayanian, John Z.
Keating, Nancy L.
Polgreen, Linnea A.
Wallace, Robert
Ganz, Patricia A.
and
Weeks, Jane C.
2010.
Employment Among Survivors of Lung Cancer and Colorectal Cancer.
Journal of Clinical Oncology,
Vol. 28,
Issue. 10,
p.
1700.
Danese, Mark D.
Lalla, Deepa
Brammer, Melissa
Doan, Quan
and
Knopf, Kevin
2010.
Estimating recurrences prevented from using trastuzumab in HER‐2/neu–positive adjuvant breast cancer in the United States.
Cancer,
Vol. 116,
Issue. 24,
p.
5575.
Ivanaūskienė, Rugile
Padaiga, Žilvinas
Vanagas, Giedrius
and
Juozaitytė, Elona
2010.
Indirect costs of breast cancer in Lithuania in 2008.
Polish Annals of Medicine,
Vol. 17,
Issue. 1,
p.
25.
Kimman, M.L.
Dirksen, C.D.
Voogd, A.C.
Falger, P.
Gijsen, B.C.M.
Thuring, M.
Lenssen, A.
van der Ent, F.
Verkeyn, J.
Haekens, C.
Hupperets, P.
Nuytinck, J.K.S.
van Riet, Y.
Brenninkmeijer, S.J.
Scheijmans, L.J.E.E.
Kessels, A.
Lambin, Ph.
and
Boersma, L.J.
2011.
Economic evaluation of four follow-up strategies after curative treatment for breast cancer: Results of an RCT.
European Journal of Cancer,
Vol. 47,
Issue. 8,
p.
1175.
Foster, Talia S.
Miller, Jeffrey D.
Boye, Mark E.
Blieden, Marissa B.
Gidwani, Risha
and
Russell, Mason W.
2011.
The economic burden of metastatic breast cancer: A systematic review of literature from developed countries.
Cancer Treatment Reviews,
Garau, Martina
Shah, Koonal
Sharma, Priya
and
Towse, Adrian
2013.
Is the Link between Health and Wealth Considered in Decision Making? Results from a Qualitative Study.
SSRN Electronic Journal,
Lauzier, Sophie
Lévesque, Pascale
Mondor, Myrto
Drolet, Mélanie
Coyle, Douglas
Brisson, Jacques
Mâsse, Benoît
Provencher, Louise
Robidoux, André
and
Maunsell, Elizabeth
2013.
Out-of-Pocket Costs in the Year After Early Breast Cancer Among Canadian Women and Spouses.
JNCI: Journal of the National Cancer Institute,
Vol. 105,
Issue. 4,
p.
280.
Wan, Yin
Gao, Xin
Mehta, Sonam
Wang, Zhixiao
Faria, Claudio
and
Schwartzberg, Lee
2013.
Indirect costs associated with metastatic breast cancer.
Journal of Medical Economics,
Vol. 16,
Issue. 10,
p.
1169.
Färkkilä, Niilo
Torvinen, Saku
Sintonen, Harri
Saarto, Tiina
Järvinen, Heikki
Hänninen, Juha
Taari, Kimmo
and
Roine, Risto P.
2015.
Costs of colorectal cancer in different states of the disease.
Acta Oncologica,
Vol. 54,
Issue. 4,
p.
454.
Gandhi, S.
Verma, S.
Ethier, J.-L.
Simmons, C.
Burnett, H.
and
Alibhai, S.M.H.
2015.
A systematic review and quality appraisal of international guidelines for early breast cancer systemic therapy: Are recommendations sensitive to different global resources?.
The Breast,
Vol. 24,
Issue. 4,
p.
309.
Ivanauskienė, Rugilė
Domeikienė, Auksė
Kregždytė, Rima
Milašauskienė, Žemyna
and
Padaiga, Žilvinas
2015.
The cost of newly diagnosed breast cancer in Lithuania, 2011.
Medicina,
Vol. 51,
Issue. 1,
p.
63.